TNKS and cancer: Thus, the therapeutic relevance of inhibiting the Wnt pathway in cancer remains, and multiple drugs that inhibit Wnt signaling are showing promise for clinical application (e.g., inhibitors of Wnt secretion, tankyrase 1/2 inhibitors, and inhibitors of β-catenin interactions) [42].